NO932875L - Preparater i form av faste partikler som inneholder virksomme substanser, fremgansmaate for fremstilling, samt anvendelse - Google Patents

Preparater i form av faste partikler som inneholder virksomme substanser, fremgansmaate for fremstilling, samt anvendelse

Info

Publication number
NO932875L
NO932875L NO932875A NO932875A NO932875L NO 932875 L NO932875 L NO 932875L NO 932875 A NO932875 A NO 932875A NO 932875 A NO932875 A NO 932875A NO 932875 L NO932875 L NO 932875L
Authority
NO
Norway
Prior art keywords
preparations
containing active
water
preparation
methods
Prior art date
Application number
NO932875A
Other languages
English (en)
Other versions
NO932875D0 (no
NO307811B1 (no
Inventor
Sven Grabowski
Axel Sanner
Joerg Rosenberg
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO932875D0 publication Critical patent/NO932875D0/no
Publication of NO932875L publication Critical patent/NO932875L/no
Publication of NO307811B1 publication Critical patent/NO307811B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
NO932875A 1992-08-13 1993-08-12 Preparater i form av faste partikler som inneholder virksomme substanser, samt anvendelse NO307811B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4226753A DE4226753A1 (de) 1992-08-13 1992-08-13 Wirkstoffe enthaltende Zubereitungen in Form fester Teilchen

Publications (3)

Publication Number Publication Date
NO932875D0 NO932875D0 (no) 1993-08-12
NO932875L true NO932875L (no) 1994-02-14
NO307811B1 NO307811B1 (no) 2000-06-05

Family

ID=6465437

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932875A NO307811B1 (no) 1992-08-13 1993-08-12 Preparater i form av faste partikler som inneholder virksomme substanser, samt anvendelse

Country Status (12)

Country Link
US (1) US5641516A (no)
EP (1) EP0596203B1 (no)
JP (1) JPH06172160A (no)
AT (1) ATE186638T1 (no)
AU (1) AU661407B2 (no)
CA (1) CA2103961C (no)
DE (2) DE4226753A1 (no)
DK (1) DK0596203T3 (no)
ES (1) ES2140428T3 (no)
GR (1) GR3031871T3 (no)
MX (1) MX9304658A (no)
NO (1) NO307811B1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK281042B6 (sk) 1992-09-18 2000-11-07 Yamanouchi Pharmaceutical Co., Ltd Prípravok hydrogélového typu s ustáleným uvoľňovaním
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
WO1995031900A1 (fr) * 1994-05-24 1995-11-30 Nippon Shinyaku Co., Ltd. Composition pesticide et procede pour sa preparation
FR2725624B1 (fr) * 1994-10-14 1997-01-17 Jouveinal Inst Rech Procede de preparation de formes pharmaceutiques a liberation controlee
DE19504831A1 (de) * 1995-02-14 1996-09-05 Basf Ag Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
SI9500173B (sl) * 1995-05-19 2002-02-28 Lek, Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
DE19531277A1 (de) 1995-08-25 1997-02-27 Basf Ag Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren
DE19531684A1 (de) * 1995-08-29 1997-03-06 Bayer Ag Verfahren zur Herstellung von Arzneimittelzubereitungen mit kontrollierter Freisetzung
CA2240161C (en) 1996-05-20 2005-05-24 Janssen Pharmaceutica N.V. Antifungal compositions with improved bioavailability
DE19710009A1 (de) * 1997-03-12 1998-09-24 Knoll Ag Mehrphasige wirkstoffhaltige Zubereitungsformen
HN1998000115A (es) * 1997-08-21 1999-06-02 Warner Lambert Co Formas de dosificación farmacéuticas sólidas
EP1026946A1 (de) * 1997-10-29 2000-08-16 Basf Aktiengesellschaft Feste zubereitung eines pflanzenschutzmittels
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
DE19934610A1 (de) * 1999-07-23 2001-01-25 Bayer Ag Schnellfreisetzende Extrudate und Verfahren zu ihrer Herstellung sowie daraus erhältliche Zubereitungen
DE60028754T2 (de) * 1999-11-12 2007-05-31 Abbott Laboratories, Abbott Park Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
DE10215147A1 (de) * 2002-04-05 2003-10-16 Basf Ag Verwendung von Polymerisation, enthaltend thermoplastische Polymere als Filterhilfs- und/oder Stabilisierungsmittel
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
EP1832281A1 (en) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Process for producing a solid dispersion of an active ingredient
ES2557165T3 (es) 2006-04-12 2016-01-22 Nippon Soda Co., Ltd. Método para producir una tableta de liberación sostenida
ITPI20060098A1 (it) 2006-07-28 2008-01-29 Antonio Maccari Sistema di controllo della funzionalita' degli ugelli di una testina di stampa.
CA2669938C (en) * 2006-11-15 2016-01-05 Abbott Laboratories Solid pharmaceutical dosage formulations
JP6854162B2 (ja) * 2017-03-17 2021-04-07 ライオン株式会社 錠剤
TWI692499B (zh) * 2019-07-19 2020-05-01 怡定興科技股份有限公司 用於微針貼片之針底組成物及包含其之微針貼片

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636865A (no) * 1962-08-31
GB1388786A (en) * 1972-04-03 1975-03-26 Scherer Corp R P Integral solid gel-lattice dosage form of high-moisture content
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
US4832957A (en) * 1987-12-11 1989-05-23 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
US4814168A (en) * 1988-03-04 1989-03-21 Noven Pharmaceuticals, Inc. Transdermal multipolymer drug delivery system
DE3830353A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
US5273760A (en) * 1991-12-24 1993-12-28 Euroceltigue, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer

Also Published As

Publication number Publication date
EP0596203B1 (de) 1999-11-17
NO932875D0 (no) 1993-08-12
AU661407B2 (en) 1995-07-20
ATE186638T1 (de) 1999-12-15
EP0596203A1 (de) 1994-05-11
DE4226753A1 (de) 1994-02-17
MX9304658A (es) 1994-02-28
DK0596203T3 (da) 2000-03-13
CA2103961A1 (en) 1994-02-14
JPH06172160A (ja) 1994-06-21
AU4457293A (en) 1994-02-17
GR3031871T3 (en) 2000-02-29
DE59309876D1 (de) 1999-12-23
ES2140428T3 (es) 2000-03-01
NO307811B1 (no) 2000-06-05
US5641516A (en) 1997-06-24
CA2103961C (en) 2005-08-09

Similar Documents

Publication Publication Date Title
NO932875L (no) Preparater i form av faste partikler som inneholder virksomme substanser, fremgansmaate for fremstilling, samt anvendelse
AU608584B2 (en) Stable interferon complexes
ATE87319T1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
AU5290490A (en) Spray gel base and spray gel preparation using thereof
KR900001362A (ko) 마이크로-입자 및/또는 나노-입자로 구성된 신규한 고체 다공성 단위형태 및 그것의 제조
EP0474785A4 (en) Percutaneous lymphography
CA2220871A1 (en) Peptide/protein suspending formulations
DE60137452D1 (de) Pulverzubereitungen und verfahren zu ihrer herstellung
EP0466816A4 (en) Method for enhancing transmembrane transport of exogenous molecules
ES8306019A1 (es) Un metodo de revestimiento de un material solido farmaceuti-co
DK0777964T3 (da) Fremgangsmåde til fremstilling af et doseringssystem
JPS6445318A (en) Delivery system for administration control of lhrh analogue
ES525794A0 (es) Procedimiento para la preparacion de un granulado de polimero
ATE238070T1 (de) Komplex aus carrageenan und einem wasserlöslichen medikament mit einer spezifischen granulometrie und entsprechende pharmazeutische zusammensetzungen mit gesteuerter freisetzung
EP0173664A3 (en) Biologically active benzimidazole compounds and process for their preparation
ATE295151T1 (de) Sprühbeschichtete mikropartikel für nadellose spritzen
AU2923389A (en) A pharmaceutical composition
FI871116A0 (fi) Kontrollerbart frigoerande nifedipinprodukter.
ATA379182A (de) Verfahren zur herstellung von presslingen mit retardierter wirkstofffreisetzung
DK164019C (da) Stabiliseret flydende laegemiddelpraeparat indeholdende ioniske laegemidler med protraheret virkning samt fremgangsmaade til fremstilling deraf
AU6839890A (en) Pharmaceutical preparation for oral administration in fluid form
Young et al. EFFECT OF THROMBOSPONDIN AND OTHER PLATELET α–GRANULE PROTEINS ON ARTIFICIAL SURFACE–INDUCED THROMBOSIS
Rashidbaigi et al. [46] Binding of 32P-labeled human recombinant immune interferon to U937 cells
COLEMAN et al. Proceedings of the 6 th International Conference on Positron Annihilation: Program and collected abstracts[Final Report, Jan.- Nov. 1982]
Zlobina New Compositions Based on Filled Polyolefins

Legal Events

Date Code Title Description
MK1K Patent expired